Big pharma company Eli Lilly (LLY 1.19%) faces allegations of bribing medical doctors in China, just weeks after similar claims arose against its peers GlaxoSmithKline and Sanofi. In the following video, taken from The Motley Fool's health-care show, analysts David Williamson and Max Macaluso discuss this story and the potential impact of these claims on investors.
Free Article
You're reading a free article with opinions that may differ from The Motley Fool's Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.